![Eugenio A. Cefali](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugenio A. Cefali
Keine laufenden Positionen mehr
Profil
Eugenio A.
Cefali worked as a Senior Scientist at Schering-Plough Corp.
He then worked as Vice President-Clinical Development at KOS Pharmaceuticals, Inc. from 1994 to 2007.
Later, he worked as Senior Vice President-Clinical Pharmacology at Cortria Corp.
from 2009 to 2010.
He also worked as a Manager at Whitby Research, Inc. Dr. Cefali completed his undergraduate degree at St. John's University and his doctorate degree at Virginia Commonwealth University.
Ehemalige bekannte Positionen von Eugenio A. Cefali
Unternehmen | Position | Ende |
---|---|---|
KOS Pharmaceuticals, Inc.
![]() KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01.01.2007 |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Whitby Research, Inc. | Corporate Officer/Principal | - |
Cortria Corp.
![]() Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Eugenio A. Cefali
St. John's University | Undergraduate Degree |
Virginia Commonwealth University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
KOS Pharmaceuticals, Inc.
![]() KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Cortria Corp.
![]() Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
Whitby Research, Inc. | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |